| 1 | RGC32
|
| Epigenetic modifications induced by RGC-32 in colon cancer.
|
| Vlaicu SI, Tegla CA, Cudrici CD, Fosbrink M, Nguyen V, Azimzadeh P, Rus V, Chen H, Mircea PA, Shamsuddin A, Rus H.
|
| Exp Mol Pathol 88(1):67-76. Epub 2009 Oct 31.
2010
|
| 2 | RGC32
|
| Response gene to complement 32, a novel hypoxia-regulated angiogenic inhibitor.
|
| An X, Jin Y, Guo H, Foo SY, Cully BL, Wu J, Zeng H, Rosenzweig A, Li J.
|
| Circulation 120(7):617-27. Epub 2009 Aug 3.
2009
|
| 3 | RGC32
|
| Response gene to complement 32 expression is induced by the luteinizing hormone (LH) surge and regulated by LH-induced mediators in the rodent ovary.
|
| Park ES, Choi S, Muse KN, Curry TE Jr, Jo M.
|
| Endocrinology 149(6):3025-36. Epub 2008 Feb 28.
2008
|
| 4 | RGC32
|
| RGC32, a novel p53-inducible gene, is located on centrosomes during mitosis and results in G2/M arrest.
|
| Saigusa K, Imoto I, Tanikawa C, Aoyagi M, Ohno K, Nakamura Y, Inazawa J.
|
| Oncogene 26(8):1110-21. Epub 2006 Dec 4.
2007
|
| 5 | RGC32
|
| Overexpression of RGC-32 in colon cancer and other tumors.
|
| Fosbrink M, Cudrici C, Niculescu F, Badea TC, David S, Shamsuddin A, Shin ML, Rus H.
|
| Exp Mol Pathol 78(2):116-22. Epub 2005 Jan 5. 2005
|
| 6 | CDK1, RGC32
|
| RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase.
|
| Badea T, Niculescu F, Soane L, Fosbrink M, Sorana H, Rus V, Shin ML, RusH.
|
| J Biol Chem 277(1):502-8. Epub 2001 Oct 30. 2002
|